WPD PHARMACEUTICALS’ WP1122 DRUG TO BE TESTED ON A RANGE OF VIRUSES INCLUDING CORONAVIRUS
March 19, 2020 03:05 ET
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, March 19, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company, announces, that its...
CENTOGENE Announces Commencement of Testing for COVID-19
March 18, 2020 14:13 ET
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Germany, March 18, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms...
WPD PHARMACEUTICALS ANNOUNCES BRAIN CANCER PATIENT FROM BERUBICIN PHASE 1 TRIAL REMAINS CANCER FREE
March 16, 2020 09:30 ET
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, March 16, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company, is pleased to...
WPD PHARMACEUTICALS RECEIVED $800,000 REIMBURSEMENT FROM $7.4 MILLION GOVERNMENT GRANT FOR DEVELOPMENT OF GLIOBLASTOMA DRUG
March 11, 2020 16:05 ET
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, March 11, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company, is pleased to...
How Best to Fix the US Healthcare System? For Physicians, It Starts with Affordability and Access, Says InCrowd Data
February 27, 2020 11:00 ET
|
InCrowd, Inc
WATERTOWN, Mass., Feb. 27, 2020 (GLOBE NEWSWIRE) -- As healthcare reform dominates political discourse, those who know the US healthcare market perhaps best—US physicians—reported significantly...
Phathom Pharmaceuticals to Present at 40th Annual Cowen and Company Health Care Conference on March 2, 2020
February 25, 2020 16:35 ET
|
Phathom Pharmaceuticals
FLORHAM PARK, N.J., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel...
WPD Pharmaceuticals Granted Key Patent Exclusively Licensed From Wake Forest University
February 24, 2020 03:05 ET
|
WPD Pharmaceuticals
VANCOUVER, British Columbia , Feb. 24, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, is pleased to...
WPD Pharmaceuticals' STAT3 Inhibitor Received FDA Approval of IND Status in Pediatric Brain Cancer Trial
February 20, 2020 03:05 ET
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, Feb. 20, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company is pleased to provide...
WPD Pharmaceuticals’ WP1220 Drug Demonstrates Median Reduction of 56% in Skin Cancer Lesions in Clinical Trials
February 18, 2020 07:35 ET
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, Feb. 18, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, in collaboration...
Voyageur Pharmaceuticals Implements Frances Creek Environmental Strategy for Bulk Sample and Future Quarry Production
February 18, 2020 07:00 ET
|
Voyageur Pharmaceuticals Ltd.
CALGARY, Alberta, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSXV:VM) (the "Company" or "Voyageur") is implementing steps to ensure the Frances Creek barium sulfate project...